Follicum is a pharmaceutical company. The greatest focus is on the development of drug candidates that stimulate hair growth in patients. Currently products are held that may stimulate hair growth, but also hamper the degree of hair growth, mainly derived from hirsutism, which implicates unusually large production of hair in women. The pharmaceutical consists of endogenous, human proteins, which influence the processing of hair follicles. The company was established in 2011 and is based in Lund.

Quotes for Follicum AB

Right Now

+/-
-0.09
%
-3,35%
Latest
2.6
High
2.97
Low
2.5
Volume
292 935
Turnover (SEK)
761 615
Value (MSEK)
175,8

Board

CEO

  • Jan Alenfall

Chairman Of The Board

  • Gun-Britt Fransson

Board

  • Alejandra Mørk
  • Anna Hultgårdh Nilsson
  • Carl-Johan Spak
  • Lars H. Bruzelius
  • Mats Persson

Videos

Largest Owners

Name Capital % Votes % Date
Swedish Growth Fund 12,41 12,41 2019-09-30
Avanza Pension 9,15 9,15 2019-09-30
Recipharm Venture Fund AB 5,38 5,38 2019-09-30
Brushamn Invest AB 4,14 4,14 2019-09-30
Tibia Konsult AB 3,41 3,41 2019-09-30
Mats Paulssons Stiftelse För Forskning Innovation Samhällsbygg 3,36 3,36 2019-09-30
Nordnet Pensionsförsäkring 3,28 3,28 2019-09-30
Mats Lundberg 2,69 2,69 2019-09-30
Kudu AB 2,03 2,03 2019-09-30
Nordic Cross Asset Management 1,69 1,69 2019-08-31
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream